UCB Ventures
Overview
UCB Ventures is the evergreen strategic corporate venture fund of UCB, a global biopharmaceutical company, that invests in early-stage companies in the US and Europe developing novel therapeutic modalities and platforms.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Switch Therapeutics | Mar 2023 | Series A | Lead |
| Seamless Therapeutics | Apr 2024 | Seed | Co-investor |
| Rinri Therapeutics | May 2021 | Grant | Co-investor |
| Iris Medicine | May 2020 | Seed | Co-investor |
| Neurava | Apr 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is UCB Ventures based?
UCB Ventures is headquartered in Brussels, Belgium.
When was UCB Ventures founded?
UCB Ventures was founded in 2017.
How many portfolio companies does UCB Ventures have?
UCB Ventures has 14 portfolio companies in Caplight's dataset.
What are some companies in UCB Ventures's portfolio?
Portfolio companies visible on Caplight include Switch Therapeutics, Seamless Therapeutics, Rinri Therapeutics, Iris Medicine, Neurava.
What was UCB Ventures's most recent investment shown here?
UCB Ventures's most recent investment in this portfolio sample was in Seamless Therapeutics in 2024.
What sectors does UCB Ventures focus on?
UCB Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does UCB Ventures focus on?
UCB Ventures typically invests at the Mid stage.
What is UCB Ventures's AUM?
UCB Ventures's assets under management are estimated between $165.0M and $165.0M.